Altre lingue Bellerophon Therapeutics, Inc.

Azioni

BLPH

US0787713009

Tempo differito OTC Markets Altri mercati azionari 19:56:35 02/05/2024			Variaz. 5gg	Var. 1 gen.
0,0625 ^USD	+21,83%		+13,64%	+68,92%

04/03	Bellerophon Therapeutics, Inc. annuncia le dimissioni di Mary Ann Cloyd e Scott Bruder da membri del Consiglio di amministrazione	CI
2023	Bellerophon Therapeutics, Inc. annuncia cambiamenti esecutivi	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

North American Morning Briefing : Stock Futures -2-	02/05
North American Morning Briefing : More Tech -2-	25/04
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11/04
North American Morning Briefing : Focus Turns to -2-	04/04
North American Morning Briefing : Stocks Set for -2-	28/03
Bellerophon Therapeutics, Inc. Announces Resignation of Mary Ann Cloyd and Scott Bruder as Members of Board of Directors	04/03
Bellerophon Therapeutics, Inc. Announces Executive Changes	21/11
Bellerophon Therapeutics, Inc. Announces Executive Changes	21/11
North American Morning Briefing : Stocks Futures Steady on Rates Optimism	20/11
Bellerophon Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Bellerophon Therapeutics, Inc.(NasdaqCM:BLPH) dropped from S&P TMI Index	18/10/23
Bellerophon Therapeutics Insider Sold Shares Worth $111,776, According to a Recent SEC Filing	17/10/23
Bellerophon Therapeutics, Inc. Announces Resignation of Theodore Wang as a Member of the Company's Board	13/10/23
Bellerophon Therapeutics, Inc.(OTCPK:BLPH) dropped from NASDAQ Composite Index	13/10/23
North American Morning Briefing : Focus Shifts to -2-	21/08/23
Bellerophon Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Investors Parse Inflation Data as Wall Street Set to Open Higher in Friday Trading	28/07/23
Bellerophon Therapeutics, Inc. Announces Resignation of Crispin Teufel as Board of Director	14/07/23
Bellerophon Therapeutics : Costs Associated with Exit/Disposal - Form 8-K	29/06/23
Bellerophon Therapeutics Announces Separation of Peter Fernandes as Chief Executive Officer, Effective July 15, 2023	29/06/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bellerophon Therapeutics, Inc.

Azioni

BLPH

US0787713009

Altre lingue

Filtri